Home » Newsletters » BioWorld

BioWorld

June 22, 1993

View Archived Issues

HYGEIA GETS SBIR GRANT

IDEC GETS PATENT ALLOWANCE

MIT CONFERENCE FOCUSES ON TECHNOLOGY POLICY IN '90S

MOUSE ALTERED TO FACILITATE STUDY OF BONE RESORBTION

APPOINTMENTS AND ADVANCEMENTS

BECKMAN TO SELL SEPRACOR'S HDLC MEDIA

OPHIDIAN GETS SBIR TO DEVELOP ANTITOXINS

PDL DRUGS GETS ORPHAN DRUG STATUS

IGI AWARDED PATENT

FDA TO STANDARDIZE TERMINOLOGY FOR REVIEWS

GORE MEETS WITH INDUSTRY LEADERS

CYTOTHERAPEUTICS BEGINS TRIALS

CELLEX GETS $500,000 SBIR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...